Pure Global

"Aber" Brierling Respiratory Fusion Virus Antigen Diagnostic Reagent (Non-sterilized) - Taiwan Registration e48dc0b4a344c4350fa0c8541a04bb7d

Access comprehensive regulatory information for "Aber" Brierling Respiratory Fusion Virus Antigen Diagnostic Reagent (Non-sterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number e48dc0b4a344c4350fa0c8541a04bb7d and manufactured by Abbott Diagnostics Korea Inc.. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
e48dc0b4a344c4350fa0c8541a04bb7d
Registration Details
Taiwan FDA Registration: e48dc0b4a344c4350fa0c8541a04bb7d
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Aber" Brierling Respiratory Fusion Virus Antigen Diagnostic Reagent (Non-sterilized)
TW: "ไบžๅŸน" ็™พ่€Œ้ˆๅ‘ผๅธ้“่žๅˆ็—…ๆฏ’ๆŠ—ๅŽŸ่จบๆ–ท่ฉฆๅŠ‘(ๆœชๆป…่Œ)
Risk Class 1

Registration Details

e48dc0b4a344c4350fa0c8541a04bb7d

DHA09402331400

Company Information

Korea, Republic of

Product Details

Limited to the classification and grading management of medical devices, the first level identification range of "respiratory fusion cell virus serum reagent (C.3480)".

C Immunology and microbiology

C.3480 ๅ‘ผๅธ้“่žๅˆ็ดฐ่ƒž็—…ๆฏ’่ก€ๆธ…่ฉฆๅŠ‘

Input;; QMS/QSD

Dates and Status

Nov 21, 2023

Nov 21, 2028